4D Molecular Therapeutics (FDMT) Non-Current Debt (2026)
4D Molecular Therapeutics' Non-Current Debt came in at $19.59 million for Q2 2026.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Non-Current Debt (2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,152.37 Bn | 1,120.96 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 628.86 Bn | 547.39 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 500.37 Bn | 473.48 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 374.01 Bn | 328.39 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 300.56 Bn | 264.55 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 263.92 Bn | 237.60 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 238.37 Bn | 193.77 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 192.21 Bn | 166.40 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 171.20 Bn | 117.84 Bn | 10.94 Bn | 60.50 Bn |
| 10 | 4D Molecular Therapeutics | 899.48 Mn | -560.46 Mn | - | 19.59 Mn |
API Access
4D Molecular Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();